Sign in

NEULANDLAB on National Stock Exchange of India

Neuland Laboratories

Logo: neulandlabs.com4

Indian pharmaceutical company

Neuland Laboratories Limited is an Indian publicly listed contract development and manufacturing organization (CDMO) headquartered in Hyderabad. Founded in 1984, the company produces active pharmaceutical ingredients (APIs), advanced intermediates, and peptide APIs. Its shares are traded on the Bombay Stock Exchange and the National Stock Exchange.2 Its shares trade on National Stock Exchange of India under the symbol NEULANDLAB.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1984Founded1

Compare with another stock.

  • TickerNEULANDLAB on National Stock Exchange of India1
  • Industrypharmaceutical industry1
  • HeadquartersHyderabad1
  • Websitewww.neulandlabs.com/en
  • Legal formlimited company1
  • Listed onBombay Stock Exchange (524558), National Stock Exchange of India (NEULANDLAB)1
  • LEI335800AVHZURTYQ17N083
  • StatusActive3
  • LEI statusIssued and current3
  • Registered address11TH FLOOR (5TH LEVEL) PHOENIX IVY BUILDING PLOT NO. 573A-III, ROAD NO. 82 JUBILEE HILLS,, 500033 Hyderabad, India3
  • Registered withMinistry of Corporate Affairs, L85195TG1984PLC0043933

See how the biggest companies compare on our leaderboards

Neuland Laboratories image from its website
Image: neulandlabs.com4

Neuland Laboratories Limited is an Indian publicly listed contract development and manufacturing organization (CDMO) headquartered in Hyderabad. Founded in 1984, the company produces active pharmaceutical ingredients (APIs), advanced intermediates, and peptide APIs. Its shares are traded on the Bombay Stock Exchange and the National Stock Exchange.2

Products and brands

Product development

The company's operations are divided into three segments: Custom Manufacturing Solutions, which develops APIs from pre-clinical to commercial stages; Generic Drug Substances, which manufactures non-exclusive APIs; and a Peptide API unit that specializes in peptide synthesis.

Facilities

Neuland Laboratories operates multiple world-class facilities supporting active pharmaceutical ingredient (API), intermediate, and peptide production.

Unit I – Bonthapally: The primary manufacturing hub situated in Bonthapally village, Medak District, Telangana, with multiple production blocks including kilo labs and quality assurance laboratories. It holds approvals from major regulatory agencies and supports commercial API production.

Unit II – Pashamylaram: A large-scale manufacturing facility comprising multiple production blocks, an engineering workshop, and warehouses.

Read the full text

Unit III – Gaddapotharam: A multi-product facility designed for advanced intermediates and APIs, with analytical development and pilot plant capabilities.

R&D Centre – Bonthapally: Research and development centre with a team of approximately 360 scientists, pilot labs, and analytical capabilities to catalyze process development and technology transfer.

Upcoming Peptide Facility

Neuland Laboratories is set to commission a new commercial peptide manufacturing facility at its 17- acre Bonthapally manufacturing campus in the summer of 2026. The project is part of a phased expansion, with additional capacity planned in line with growing client demand. The first of four modules is expected to be operational by mid-2026, adding commercial scale capabilities to its existing peptide manufacturing infrastructure.

The new peptide manufacturing facility will feature digitalized operations supported by distributed control system (DCS) automation and electronic batch‑record platforms. It is also designed with expanded purification and drying infrastructure, including multi‑column preparative HPLC systems, large‑scale lyophilizers, enhanced solvent‑handling capabilities, and upgraded waste‑management processes. These features are intended to support consistent batch quality and more efficient production cycles.

From Wikipedia’s article on Neuland Laboratories, shared under CC BY-SA 4.0.5

Timeline

  1. 1984Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5